BBVA USA Bancshares’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$12.1M Buy
102,334
+3,107
+3% +$364K 0.58% 37
2020
Q4
$11.6M Sell
99,227
-5,315
-5% -$585K 0.6% 32
2020
Q3
$10.6M Buy
104,542
+3
+0% +$301 0.61% 34
2020
Q2
$9.59M Buy
104,539
+80
+0.1% +$7.67K 0.57% 37
2020
Q1
$9.42M Buy
104,459
+10,919
+12% +$1.16M 0.68% 29
2019
Q4
$10.6M Buy
93,540
+1,213
+1% +$133K 0.6% 36
2019
Q3
$10M Buy
92,327
+7,980
+9% +$833K 0.65% 37
2019
Q2
$8.21M Sell
84,347
-4,010
-5% -$366K 0.5% 48
2019
Q1
$8.05M Sell
88,357
-1,280
-1% -$115K 0.51% 48
2018
Q4
$8.15M Buy
89,637
+2,526
+3% +$236K 0.58% 41
2018
Q3
$8.57M Buy
87,111
+715
+0.8% +$66.1K 0.51% 44
2018
Q2
$7.4M Buy
86,396
+6,906
+9% +$577K 0.47% 50
2018
Q1
$6.38M Buy
79,490
+1,167
+1% +$96.3K 0.41% 60
2017
Q4
$6.33M Sell
78,323
-6,654
-8% -$533K 0.4% 62
2017
Q3
$6.61M Sell
84,977
-8,705
-9% -$723K 0.43% 55
2017
Q2
$8.31M Buy
93,682
+12,480
+15% +$1.05M 0.55% 46
2017
Q1
$6.54M Buy
81,202
+3,722
+5% +$291K 0.44% 59
2016
Q4
$5.52M Sell
77,480
-8,466
-10% -$665K 0.39% 64
2016
Q3
$7.42M Buy
85,946
+3,808
+5% +$332K 0.54% 48
2016
Q2
$7.13M Buy
82,138
+16,409
+25% +$1.33M 0.53% 44
2016
Q1
$4.93M Buy
65,729
+42,784
+186% +$3.22M 0.37% 67
2015
Q4
$1.76M Buy
22,945
+14,440
+170% +$1.09M 0.13% 157
2015
Q3
$569K Sell
8,505
-28,181
-77% -$2.08M 0.04% 302
2015
Q2
$2.72M Buy
36,686
+7,760
+27% +$593K 0.15% 144
2015
Q1
$2.26M Buy
28,926
+157
+0.5% +$11.9K 0.1% 185
2014
Q4
$2.08M Buy
28,769
+7,654
+36% +$532K 0.09% 192
2014
Q3
$1.31M Sell
21,115
-587
-3% -$37.3K 0.06% 239
2014
Q2
$1.38M Sell
21,702
-62
-0.3% -$3.77K 0.06% 238
2014
Q1
$1.34M Sell
21,764
-121
-0.6% -$7.05K 0.06% 227
2013
Q4
$1.26M Buy
21,885
+4,583
+26% +$260K 0.05% 246
2013
Q3
$922K Sell
17,302
-579
-3% -$31.2K 0.04% 258
2013
Q2
$921K Buy
+17,881
New +$884K 0.05% 250

Other funds holding MDT

BBVA USA Bancshares's MDT Position: Q1 2021 in Review

BBVA USA Bancshares increased its Medtronic (MDT) stake by 3.1% in Q1 2021, buying an estimated $364K and bringing the position to 102,334 shares worth $12.1M. The position accounts for 0.58% of the portfolio, ranked #37.

BBVA USA Bancshares first reported a position in MDT in Q2 2013 and has held it in 32 quarters since. 1,977 funds tracked by Wall St. Rank hold MDT as of Q1 2021.

  • BBVA USA Bancshares held 102,334 shares of Medtronic worth $12.1M as of Q1 2021.
  • BBVA USA Bancshares bought 3,107 Medtronic shares in Q1 2021, an estimated $364K.
  • Medtronic made up 0.58% of BBVA USA Bancshares's portfolio in Q1 2021, its #37 holding.
  • BBVA USA Bancshares first reported a position in Medtronic in Q2 2013 and has held it in 32 quarters since.
  • 1,977 funds tracked by Wall St. Rank held Medtronic as of Q1 2021.

Based on BBVA USA Bancshares's 13F filing for Q1 2021, filed 23 Apr 2021.